Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.
Cite this article
Patients with diabetes mellitus, chronic renal disease, or advanced age who are undergoing percutaneous coronary intervention are at an increased risk of bleeding and thrombosis. This article reviews the clinical implications of these conditions and discusses the therapeutic options currently available for these patient groups.
Percutaneous coronary intervention
Plasminogen activator inhibitor 1
Chronic renal disease